ATE557103T1 - Verfahren zur erkennung von nukleinsäuresequenzen in urin - Google Patents

Verfahren zur erkennung von nukleinsäuresequenzen in urin

Info

Publication number
ATE557103T1
ATE557103T1 AT10161334T AT10161334T ATE557103T1 AT E557103 T1 ATE557103 T1 AT E557103T1 AT 10161334 T AT10161334 T AT 10161334T AT 10161334 T AT10161334 T AT 10161334T AT E557103 T1 ATE557103 T1 AT E557103T1
Authority
AT
Austria
Prior art keywords
nucleic acid
acid sequence
urine sample
urine
acid sequences
Prior art date
Application number
AT10161334T
Other languages
English (en)
Inventor
Anatoly V Lichtenstein
Hovsep Melkonyan
Samuil Umansky
Original Assignee
Trovagene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trovagene Inc filed Critical Trovagene Inc
Application granted granted Critical
Publication of ATE557103T1 publication Critical patent/ATE557103T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT10161334T 1997-05-30 1998-05-29 Verfahren zur erkennung von nukleinsäuresequenzen in urin ATE557103T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4817097P 1997-05-30 1997-05-30
US4838197P 1997-06-30 1997-06-30

Publications (1)

Publication Number Publication Date
ATE557103T1 true ATE557103T1 (de) 2012-05-15

Family

ID=26725864

Family Applications (3)

Application Number Title Priority Date Filing Date
AT10161334T ATE557103T1 (de) 1997-05-30 1998-05-29 Verfahren zur erkennung von nukleinsäuresequenzen in urin
AT98924998T ATE320505T1 (de) 1997-05-30 1998-05-29 Verfahren zur bestimmung von nukleinsäuresequenzen in urin
AT05077010T ATE486958T1 (de) 1997-05-30 1998-05-29 Verfahren zur bestimmung von nukleinsäuresequenzen in urin

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT98924998T ATE320505T1 (de) 1997-05-30 1998-05-29 Verfahren zur bestimmung von nukleinsäuresequenzen in urin
AT05077010T ATE486958T1 (de) 1997-05-30 1998-05-29 Verfahren zur bestimmung von nukleinsäuresequenzen in urin

Country Status (10)

Country Link
US (2) US6251638B1 (de)
EP (3) EP1634966B1 (de)
AT (3) ATE557103T1 (de)
AU (1) AU7703998A (de)
CY (1) CY1113124T1 (de)
DE (2) DE69833856T2 (de)
DK (3) DK0920539T3 (de)
ES (3) ES2355631T3 (de)
PT (1) PT2216416E (de)
WO (1) WO1998054364A1 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451523B1 (en) * 1994-09-14 2002-09-17 Interneuron Pharmaceuticals, Inc. Detection of a leptin receptor variant and methods for regulating obesity
JP3981416B2 (ja) 1997-04-10 2007-09-26 ユニバーシティ メディカル センター ナイメーヘン Ｐｃａ３タンパク質、ｐｃａ３遺伝子、及びこれらの用途
USRE39920E1 (en) * 1997-05-30 2007-11-13 Xenomics, Inc. Methods for detection of nucleic acid sequences in urine
US7060458B1 (en) * 1997-08-14 2006-06-13 Wyeth Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US20030032103A1 (en) * 1997-09-18 2003-02-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
US20030068731A1 (en) * 1997-12-17 2003-04-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030113842A1 (en) * 1998-03-11 2003-06-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7339033B2 (en) * 1998-06-26 2008-03-04 Genentech, Inc. Pro1481
US7071304B2 (en) * 1998-09-01 2006-07-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU6316100A (en) * 1999-07-30 2001-02-19 Mitsubishi Pharma Corporation Gene of human brain type pgt
JP4018304B2 (ja) * 1999-08-27 2007-12-05 独立行政法人科学技術振興機構 高親和性コリントランスポーター
PT1222266E (pt) 1999-09-29 2006-07-31 Diagnocure Inc Arn mensageiro de pca3 em tecidos benignos e malignos da prostata
EP1201681A1 (de) * 2000-10-30 2002-05-02 Millennium Pharmaceuticals, Inc. "Fail" Moleküle und deren Verwendung
US7029840B2 (en) * 2000-11-15 2006-04-18 Becton, Dickinson And Company Method for preservation of cells and nucleic acid targets
EP1368369A4 (de) * 2000-11-15 2006-02-22 Hoffmann La Roche Verfahren und reagenzien zur identifizierung seltener foetaler zellen im maternen kreislauf
US20020132998A1 (en) * 2001-01-23 2002-09-19 Friddle Carl Johan Novel human ion exchanger proteins and polynucleotides enconding the same
US20030144196A1 (en) * 2001-08-21 2003-07-31 Bowen Michael A. Activated T lymphocyte nucleic acid sequences and polypeptides encoded by same
US20030211522A1 (en) * 2002-01-18 2003-11-13 Landes Gregory M. Methods for fetal DNA detection and allele quantitation
WO2003071252A2 (en) 2002-02-15 2003-08-28 Exact Sciences Corporation Methods for analysis of molecular events
US7217515B2 (en) * 2002-09-30 2007-05-15 Chi Mei Foundation Medical Center HURP gene as a molecular marker for bladder cancer
EP1413874A1 (de) 2002-10-16 2004-04-28 Streck Laboratories, Inc. Verfahren und Vorrichtung zum Sammeln und Konservieren von Zellen für die Analyse
WO2004070056A2 (en) * 2003-02-07 2004-08-19 Diagnocure Inc. Method to detect prostate cancer in a sample
US20050227225A1 (en) * 2004-04-07 2005-10-13 Roche Molecular Systems, Inc. Stabilization of biomolecules in samples
WO2005111244A2 (en) * 2004-05-10 2005-11-24 Exact Sciences Corporation Methods for detecting a mutant nucleic acid
EP2436779B1 (de) 2004-07-23 2015-03-25 Pacific Edge Limited Urinmarker zum Nachweis von Blasenkrebs
US7981607B2 (en) * 2004-08-27 2011-07-19 Esoterix Genetic Laboratories LLC Method for detecting recombinant event
EP1812601A2 (de) * 2004-10-22 2007-08-01 Redpath Integrated Pathology, Inc. Dynamische expansion genomischer deletion und formulierung aus molekularmarkerpanels für integrierte molekulare pathologiediagnose und charakterisierung von gewebe, zellflüssigkeit und reinen flüssigproben
WO2006047787A2 (en) 2004-10-27 2006-05-04 Exact Sciences Corporation Method for monitoring disease progression or recurrence
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
ITRM20050068A1 (it) 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine.
US7914982B2 (en) * 2005-02-17 2011-03-29 Trovagene, Inc. Methods for detecting pathogen specific nucleic acids in urine
EP1885877A2 (de) 2005-02-17 2008-02-13 Istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani" IRCCS Zusammensetzungen und verfahren zum nachweis von für krankheitserreger spezifischen nukleinsäuren in urin
ITRM20050067A1 (it) * 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine.
US7449297B2 (en) * 2005-04-14 2008-11-11 Euclid Diagnostics Llc Methods of copying the methylation pattern of DNA during isothermal amplification and microarrays
WO2007044071A2 (en) * 2005-04-21 2007-04-19 Exact Sciences Corporation Analysis of heterogeneous nucleic acid samples
NZ545243A (en) * 2006-02-10 2009-07-31 Pacific Edge Biotechnology Ltd Urine gene expression ratios for detection of cancer
EP2140027B1 (de) * 2006-12-07 2012-07-18 Novartis AG Nichtinvasiver pränataler genetischer screen-test
WO2008075790A2 (en) * 2006-12-20 2008-06-26 Olympus Corporation Method for detecting cancer with nucleic acids in blood
AU2008289447B2 (en) * 2007-08-22 2014-09-04 Trovagene, Inc. Methods of using miRNA for detection of in vivo cell death
WO2009049147A2 (en) * 2007-10-10 2009-04-16 Philadelphia Health & Education Corporation D/B/A Drexel University College Of Medicine Method of tumor screening by detection of tumour marker in low molecular weight nucleic acid from urine
EP2242857A4 (de) * 2008-02-12 2011-08-17 Novartis Ag Verfahren zur isolierung zellfreier apoptotischer oder fötaler nukleinsäuren
US8709726B2 (en) * 2008-03-11 2014-04-29 Sequenom, Inc. Nucleic acid-based tests for prenatal gender determination
ES2595489T3 (es) 2008-07-18 2016-12-30 Trovagene, Inc. Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
US8476013B2 (en) * 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US11634747B2 (en) 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
ES2649572T3 (es) 2009-02-18 2018-01-12 Streck Inc. Conservación de ácidos nucleicos fuera de las células
CA2780536C (en) * 2009-11-09 2018-01-02 Streck, Inc. Stabilization of rna in and extracting from intact cells within a blood sample
US9926593B2 (en) 2009-12-22 2018-03-27 Sequenom, Inc. Processes and kits for identifying aneuploidy
CA2834218C (en) 2011-04-29 2021-02-16 Sequenom, Inc. Quantification of a minority nucleic acid species using inhibitory oligonucleotides
EP2704740B1 (de) 2011-05-04 2016-10-05 Streck, Inc. Inaktiviertes schweinegrippe-virus und verfahren zu seiner herstellung
WO2013000100A1 (en) 2011-06-29 2013-01-03 Bgi Shenzhen Co., Limited Noninvasive detection of fetal genetic abnormality
EP2820129A1 (de) 2012-03-02 2015-01-07 Sequenom, Inc. Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2014011928A1 (en) 2012-07-13 2014-01-16 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US9341628B2 (en) 2012-11-30 2016-05-17 Interpace Diagnostics Corporation Methods for measuring carcinoembryonic antigen
EP2971100A1 (de) 2013-03-13 2016-01-20 Sequenom, Inc. Primer zur analyse der dna-methylierung
CA2917912C (en) 2013-07-24 2019-09-17 Streck, Inc. Compositions and methods for stabilizing circulating tumor cells
EP3736344A1 (de) 2014-03-13 2020-11-11 Sequenom, Inc. Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
WO2016001411A1 (en) 2014-07-03 2016-01-07 Multiplicom N.V. Methods for non-invasive detection of transplant health or rejection
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
EP3491381B1 (de) 2016-07-29 2025-09-24 Streck LLC Suspensionszusammensetzung zur kontrolle einer hämatologischen analyse
WO2018064486A1 (en) 2016-09-29 2018-04-05 Counsyl, Inc. Noninvasive prenatal screening using dynamic iterative depth optimization
HUE068517T2 (hu) 2017-10-19 2024-12-28 Streck Llc A hemolízis és a véralvadás szabályozására, valamint az extracelluláris vezikulák stabilizálására szolgáló készítmények
US12270072B2 (en) 2018-06-07 2025-04-08 Biofire Diagnostics, Llc Rapid thermocycling methods
US11965217B2 (en) * 2020-07-21 2024-04-23 Delta Electronics, Inc. Method and kit for detecting Mycobacterium tuberculosis
CA3205119A1 (en) * 2020-12-15 2022-06-23 Gateway Genomics, Llc Methods, compositions, and devices for the rapid determination of fetal sex

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5541331A (en) 1991-04-30 1996-07-30 Reilly Industries, Inc. Processes for producing α-pyridyl carbinols
ATE198358T1 (de) 1992-04-27 2001-01-15 Dartmouth College Detektion von gensequenzen in biologischen flüssigkeiten
US6020124A (en) * 1992-04-27 2000-02-01 Trustees Of Dartmouth College Detection of soluble gene sequences in biological fluids
US5614402A (en) 1992-12-07 1997-03-25 Third Wave Technologies, Inc. 5' nucleases derived from thermostable DNA polymerase
US5541311A (en) 1992-12-07 1996-07-30 Third Wave Technologies, Inc. Nucleic acid encoding synthesis-deficient thermostable DNA polymerase
WO1997006819A1 (en) * 1995-08-15 1997-02-27 Alteon Inc. Compositions and methods for elmination of advanced glycosylation endproducts (in vivo)
DE19540222A1 (de) * 1995-10-18 1997-04-24 Horst Dr Schlechte Verfahren und Vorrichtung zur Gewinnung Personen- und Krankheits-spezifischer Nucleinsäure-Sequenz-Daten
DK1634890T3 (da) 1996-01-24 2009-03-09 Third Wave Tech Inc Invasiv klövning af nukleinsyrer

Also Published As

Publication number Publication date
DE69833856T2 (de) 2006-11-23
EP0920539B1 (de) 2006-03-15
ES2355631T3 (es) 2011-03-29
ES2260837T3 (es) 2006-11-01
EP1634966B1 (de) 2010-11-03
EP1634966A2 (de) 2006-03-15
PT2216416E (pt) 2012-08-16
EP0920539A1 (de) 1999-06-09
ATE320505T1 (de) 2006-04-15
ATE486958T1 (de) 2010-11-15
CY1113124T1 (el) 2016-04-13
DE69841989D1 (de) 2010-12-16
DK1634966T3 (da) 2011-02-07
US6251638B1 (en) 2001-06-26
WO1998054364A1 (en) 1998-12-03
EP1634966A3 (de) 2006-06-21
EP0920539B9 (de) 2006-08-02
DE69833856D1 (de) 2006-05-11
ES2389055T3 (es) 2012-10-22
HK1088363A1 (en) 2006-11-03
DK0920539T3 (da) 2006-07-24
EP2216416B1 (de) 2012-05-09
EP2216416A1 (de) 2010-08-11
DK2216416T3 (da) 2012-08-27
EP0920539A4 (de) 2004-06-09
AU7703998A (en) 1998-12-30
US6287820B1 (en) 2001-09-11

Similar Documents

Publication Publication Date Title
ATE557103T1 (de) Verfahren zur erkennung von nukleinsäuresequenzen in urin
ATE253645T1 (de) Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien
DE60000583D1 (de) Verfahren zur identifizierung und/oder quantifizierung einer zielverbindung
BR9916407A (pt) Detecção e tratamento de doenças dos rins
FI901917A7 (fi) Menetelmä nukleiinihapon uuttamiseksi amplifioimiseksi ja havaitsemiseksi kokoverestä tai PMBC-jakeesta
DE69433816D1 (de) Die bestimmung von nukleinsäuremutationen durch analyse des sputum
DE60041355D1 (de) Verfahren zur detektion von erkrankungen
IL124322A0 (en) Detection of an entity in a sample
ATE388402T1 (de) Verfahren zur erkennung und zum assay von nukleinsäuresequenzen
ATE302286T1 (de) Sequenzierungsverfahren mit signalverstärkern
ATE230801T1 (de) Verfahren zur detektion von zielnukleinsäure, verfahren zu ihrer quantifizierung und pyrylium- verbindungen zur chemilumineszenz-analyse
CA2317816A1 (en) Peptide detection method
DK0696642T3 (da) Fremgangsmåde til påvisning af forstyrrelser i protein C/protein S-systemet
AU4663997A (en) Detection and identification of non-polio enteroviruses
DK328584D0 (da) Immunobestemmelsesmetode for en iodthyronin i en biologisk vaeske samt reagenssystem, testsaet og testmateriale til anvendelse ved metoden
RU2007148219A (ru) Способ обнаружения бактерий и тест-набор для их обнаружения
WO2001090408A3 (fr) Detection et caracterisation de l'activite de proteines impliquees dans la reparation de lesions de l'adn
ATE315107T1 (de) Verfahren und kit zur früherkennung von krebs
DE60012723D1 (de) Verfahren zur bestimmung von disaccharidasen
DE69524199D1 (de) Primer und sonden zur amplifizierung und zum nachweis von cmv nukleinsäure
DE60121547D1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
EP1580265A4 (de) Aus einem neuroblastom in stufe 4s isoliertenukleinsäuren
EP1136568A4 (de) Methode zum ermitteln der nukleinsäure
Martin et al. A comparative study of the citrate and lactate concentrations in stains from semen, vaginal secretion and mixtures of the two using isotachophoresis
ATE269417T1 (de) Verfahren zur erkennung und messung von gespleisten nukleinsäuren